ProstateUrinary BladderUrinary Tract InfectionsProstate-Specific AntigenProstatic NeoplasmsUrinary TractUrinary IncontinenceProstatic HyperplasiaAndrogensReceptors, AndrogenUrinary RetentionProstatectomyUrinary CalculiAndrogen AntagonistsUrinary CatheterizationCell Line, TumorTransurethral Resection of ProstateOrchiectomyProstatic Intraepithelial NeoplasiaUrinary Bladder NeoplasmsUrinary Incontinence, StressUrinary Bladder DiseasesAdenocarcinomaNeoplasms, Hormone-DependentGene Expression Regulation, NeoplasticUrineProstatic DiseasesTumor Markers, BiologicalUrinary DiversionUrination DisordersDihydrotestosteroneDisease ProgressionTosyl CompoundsFinasterideDigital Rectal ExaminationUrologic DiseasesImmunohistochemistryBone NeoplasmsCase-Control StudiesMice, NudeTumor Cells, CulturedCell ProliferationNeoplasm GradingRisk Factors5-alpha Reductase InhibitorsUrinalysisAndrogen Receptor AntagonistsAnti-Infective Agents, UrinaryUrodynamicsBrachytherapyProstatitisTime FactorsApoptosisLower Urinary Tract SymptomsNeoplasm MetastasisNeoplasm StagingTestosteroneSeminal VesiclesUrinationUrinary Bladder CalculiCastrationAnilidesBiopsyBiological MarkersRNA, MessengerKidneyUrinary Incontinence, UrgeUrethraWatchful WaitingReverse Transcriptase Polymerase Chain ReactionCreatinineFlutamideUrinary Bladder Neck ObstructionBiopsy, NeedleAntineoplastic Agents, HormonalSensitivity and SpecificityAzasteroidsMetriboloneTreatment OutcomePrognosisUrinary Bladder, NeurogenicProspective StudiesNeoplasm InvasivenessAntineoplastic AgentsEpithelial CellsUrinary Bladder, OveractiveGlutamate Carboxypeptidase IINeoplasm TransplantationSignal TransductionCohort StudiesCholestenone 5 alpha-ReductaseTransplantation, HeterologousNeoplasm ProteinsXenograft Model Antitumor AssaysBlotting, Western3-Oxo-5-alpha-Steroid 4-DehydrogenaseCystitisKallikreinsProstatic Neoplasms, Castration-ResistantCarcinoma